With an overarching theme in the Indian Pharmaceutical industry of “Ideate and Innovate”, CPhI Conferences
concluded the, ‘9th Annual Pharma IPR India Conference’ on 6th March 2020 at Taj Santacruz, Mumbai.
With 230 attendees & 37 unique pharma companies, 52 distinguished speakers and 27 event partners from 5
countries, this forum experienced the congregation of the pharma intellectual property fraternity under one
Innovation is a key consideration in day-to-day business decisions. Protection of these innovations is the key
to business success. With the ever-increasing technological developments; new products, brands and creative
designs are launched daily in the market and reflects continuous human creativity. In today’s intellectual era,
Indian companies have adapted research and development (R&D) for describing its growth momentum. The
Indian government has supported the R&D culture by creating a conducive environment by upgrading infrastructure
and bringing in policy level initiatives in the country which has resulted in sweeping changes in IP
culture and administration in the country.
For the Indian companies to maximize its true potential, ideate, innovate and integrate are pre-requisites to
reaching the stupendous growth. With recent chant of ‘Atmanirbhar Bharat’ along with ‘Make in India’, ‘Start-up
India’ and ‘Digital India’ initiatives; the government of India envisages, “An India where creativity and innovation
are stimulated by Intellectual Property for the benefit of all”. It aims to defining knowledge as the main driver
of development. Intellectual Property promotes advancement in science and technology, arts and culture,
traditional knowledge and biodiversity resources.
After 9 successful edition of Pharma IPR Conference, CPhI Conferences is pleased to introduce its premier
edition of IP Conclave webinar series scheduled on 18th-19th November 2020.